Stay updated on Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed the HHS Vulnerability Disclosure link from the page footer and updated the revision label to Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:13:23.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Results have been posted and a results section added, including primary and secondary outcomes (ORR at 6 months, non-progression at 6 months, PFS, OS) with specified timeframes. Links to the Study Protocol and Statistical Analysis Plan are now available, and study results timing (Results First Posted/Submitted) has been updated.
    Difference
    8%
    Check dated 2025-12-16T03:48:21.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The PubMed publications note text was updated to indicate automatic population from PubMed. The page revision version was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:35:03.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Removed the general government funding/operating status notice from the page; no study-specific content was changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T19:18:36.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Comparison of the old and new screenshots shows no substantive changes to the study details (title, conditions, interventions, outcomes, eligibility criteria, locations); content appears unchanged aside from minor formatting tweaks. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T13:43:58.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Added government funding notice and NIH Clinical Center operating status, added new content term “Bone osteosarcoma,” and updated revision version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T04:14:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.